Chongqing Pharscin Pharmaceutical Co Ltd Capital Reinvestment Ratio
Chongqing Pharscin Pharmaceutical Co Ltd capital reinvestment ratio. Chongqing Pharscin Pharmaceutical Co Ltd (002907) has a Capital Reinvestment Ratio of 5.05x as of September 2025, meaning it reinvests 5% of its operating cash flow (CN¥833.94K) in capital expenditures (CN¥4.21 Million). Check 002907 cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Chongqing Pharscin Pharmaceutical Co Ltd (2013–2024)
Capital reinvestment ratio of Chongqing Pharscin Pharmaceutical Co Ltd from 2013 to 2024. This chart tracks Chongqing Pharscin Pharmaceutical Co Ltd's Capital Reinvestment Ratio across 12 annual periods. Also explore how fast is Chongqing Pharscin Pharmaceutical Co Ltd growing its equity to track the company's year-over-year net asset growth rate.
Chongqing Pharscin Pharmaceutical Co Ltd Capital Reinvestment Ratio by Year (2013–2024)
Chongqing Pharscin Pharmaceutical Co Ltd capital reinvestment ratio by year from 2013 to 2024. For the full cash flow conversion analysis, see cash flow conversion of Chongqing Pharscin Pharmaceutical Co Ltd.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.10x | CN¥161.77 Million | CN¥16.15 Million | ▼ -76.4% |
| 2023 | 0.42x | CN¥219.34 Million | CN¥92.82 Million | ▼ -90.9% |
| 2022 | 4.65x | CN¥13.04 Million | CN¥60.62 Million | ▲ +579.7% |
| 2021 | 0.68x | CN¥82.85 Million | CN¥56.64 Million | ▲ +66.4% |
| 2020 | 0.41x | CN¥113.64 Million | CN¥46.69 Million | ▼ -58.1% |
| 2019 | 0.98x | CN¥65.92 Million | CN¥64.66 Million | ▼ -14.1% |
| 2018 | 1.14x | CN¥31.80 Million | CN¥36.30 Million | ▲ +121.8% |
| 2017 | 0.51x | CN¥81.34 Million | CN¥41.87 Million | ▲ +78.1% |
| 2016 | 0.29x | CN¥57.73 Million | CN¥16.69 Million | ▲ +18.0% |
| 2015 | 0.25x | CN¥66.10 Million | CN¥16.20 Million | ▼ -64.1% |
| 2014 | 0.68x | CN¥20.22 Million | CN¥13.79 Million | ▲ +69.3% |
| 2013 | 0.40x | CN¥47.34 Million | CN¥19.06 Million | — |